First in Human Study of NVG-111 in Relapsed/Refractory ROR1+ Malignancies

Clinical trial NCT04763083 · UNKNOWN

Trial details

NCT number: NCT04763083
Sponsor: NovalGen Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukaemia Small Lymphocytic Lymphoma Mantle Cell Lymphoma Follicular Lymphoma Diffuse Large B Cell Lymphoma Non-small Cell Lung Cancer (NSCLC)Malignant Melanoma

Start date: 2021-05-14
Primary completion: 2023-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.